DTIL (Precision BioSciences) Insider Ownership: 28.83 % (As of Aug. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DTIL Precision BioSciences Inc DTIL
48 GF Score
Price $7.52
GF Value $1.89
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Precision BioSciences Insider Ownership?

Precision BioSciences DTIL +1.01% 48 Insider Ownership is 28.83 % as of Aug. 09, 2026. GuruFocus rates DTIL with a GF Score™ of 48/100 and a GF Value™ of $1.89 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Precision BioSciences's insider ownership is 28.83%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Precision BioSciences's Institutional Ownership is 62.74%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Precision BioSciences's Float Percentage Of Total Shares Outstanding is 97.60%.

Precision BioSciences Insider Ownership Historical Data

* Premium members only.

The historical data trend for Precision BioSciences's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precision BioSciences Insider Ownership Chart

Precision BioSciences Historical Data

The historical data trend for Precision BioSciences can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 60.98 57.36 57.40 57.40 28.16 28.81 29.18 28.83 28.83 28.83
DTIL
48GF Score
Precision BioSciences Inc DTIL
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Precision BioSciences Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 28.83 % mean?
Precision BioSciences (DTIL) has a Insider Ownership of 28.83 % as of Aug. 09, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Precision BioSciences and its competitors.
Is Precision BioSciences' Insider Ownership too high?
Precision BioSciences' current Insider Ownership is 28.83 %. Overall, Precision BioSciences has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Precision BioSciences' Insider Ownership compare to NERV and VYGR?
Precision BioSciences' Insider Ownership of 28.83 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Precision BioSciences and its competitors. Precision BioSciences's current Insider Ownership is 28.83 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precision BioSciences stock overvalued right now?
Based on GuruFocus' analysis, Precision BioSciences (DTIL) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.89, compared to a current price of $7.52 — trading 297.9% above its estimated fair value. The current Insider Ownership is 28.83 %. Precision BioSciences' overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Precision BioSciences (DTIL), the current Insider Ownership is 28.83 % as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Precision BioSciences (DTIL) Overvalued in 2026?

Based on GuruFocus' analysis, Precision BioSciences stock appears to be overvalued. The current stock price of $7.52 is trading 297.9% above its estimated GF Value™ of $1.89. GuruFocus considers Precision BioSciences to be Significantly Overvalued.

Key valuation signals for DTIL:

  • Insider Ownership: 28.83 %
  • GF Value™: $1.89 vs. price of $7.52 (297.9% above fair value)
  • GF Score™: 48/100 with 4 warning signs

No single metric tells the full story. See the DTIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Precision BioSciences Business Description

Other Exchanges PBS0:Germany
Address 302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
48GF Score

Get the complete analysis for DTIL

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.52
Price
$1.89
GF Value